LipoEdge Highlights Advanced Liposomal Zinc Supplement with 94.51% Encapsulation Efficiency and Six-Month Stability
LipoEdge highlights an advanced liposomal zinc formulation developed by WBCIL, achieving 94.51% encapsulation efficiency and maintaining excellent stability over six months under accelerated conditions. Supported by published scientific research, the formulation demonstrated a particle size of 203.1 nm and a zeta potential of -40.79 mV. These findings highlight the potential of liposomal technology for stable, scientifically characterised zinc delivery in nutraceutical and pharmaceutical applications.